Elicio Therapeutics, Inc. (Nasdaq: ELTX) (“Elicio” or the “Company”) , a clinical-stage biotechnology company developing next-generation immunotherapies for KRAS-driven cancers, today announced the ...

Emerging discoveries in liquid biomarker research promise to transform the early detection, diagnosis and treatment ...

The Public News Service Daily Newscast, July the 6th, 2026. I'm Mike Clifford. Officials say this weekend's extreme heat on ...

While more people are being diagnosed with cancer today compared with 50 years ago, the good news is that fewer people are ...

Researchers in Detroit say they have identified a naturally occurring genetic variant that appears to lower the risk of ...

Researchers in Detroit say they’ve identified a naturally occurring genetic variant that appears to lower the risk of ...

An investigational targeted therapy designed to block one of the most common genetic drivers of pancreatic cancer has shown ...

Most cancers are not inherited. Experts say regular screening, healthy habits, and early symptom recognition matter more than ...

He provided the first convincing evidence that cancerous tumors develop from a single mutated cell and later helped expose ...

Routine scans are increasingly detecting symptom-free cancers early, allowing timely treatment and improving survival, though not every abnormal finding is cancer. , Health, Times Now ...

Doctors share some key details as to why there is a relative increase in cancer cases among the younger population. They ...

Pancreatic ductal adenocarcinoma, the most common form of pancreatic cancer, is particularly deadly and hard to treat.